RE:New Focus on FCFPS Going ForwardPSDFinancier, Always glad to hear from you. Can you comment on why organic gowth in case volume is stated as 1% to 3%? My look back shows organic growth to have started at 6%...then 3% to 5%...and on this CC, 1% to 3%. Did they state that correctly? I would say that organic growth is NOT historically 1% to 3%! I believe organic growth is new case growth that occurs after acquistions. BTW, I don't see a way within their accounting to separate quarter to quarter total case growth from organic growth. Even 3% to 5% is not impressive.
"Richard K. Bear, CRH Medical Corporation - CFO & Corporate Secretary [30]
--------------------------------------------------------------------------------
I'll start with that one, Richard. So we've historically stated, organic growth in case volume of around 1% to 3%, again depending on the market and the maturity of the business. We continue to see that. We have some under-performing, we have some over-performing, but on average is 1% to 3%. These are -- remember we're servicing GIs in the ASCs. These GIs are -- these ASCs are GI specific, GIs are in private practice and they worked hard to drive volume into these centers. So I'm not -- I haven't seen MEDNAX's results, but ours are consistent with previously stated expectations. Jay, anything to add?